Pharmacological Applications of Magnetic Resonance Imaging
The DOI matches its Crossref record.
Abstract
Magnetic resonance imaging (MRI) techniques are capable of spatial and temporal resolution and within subject repeatability that far exceed other currently available methods of noninvasively investigating brain functioning. While functional MRI (fMRI) techniques have traditionally been used to investigate sensory, motor, and cognitive functions, they are also very attractive for investigating the effects of pharmacological agents in the brain. However, because pharmacological agents may interfere with the very mechanisms that give rise to the fMRI signal, careful attention to experimental design and data analysis issues must be exercised. Specifically, introducing a drug into the system could potentially alter the coupling of neural activity with regional cerebral blood flow and/or the extraction of oxygen from blood, or may cause local or global cardiovascular changes unrelated to neural activity. These concerns notwithstanding, careful attention to experimental detail and verification procedures promises to make pharmacological MRI a valuable tool for understanding the actions of drugs on the brain at many levels. The physiological and biophysical bases of blood oxygen level-dependent, arterial spin labeling, cerebral blood flow, cerebral blood volume, and spectroscopy acquisition methods are presented to illustrate where confounds may arise when a drug is added to the system. Selected studies combining administration of pharmacological agents with MRI techniques are critically reviewed to illustrate both the challenges inherent in these applications and some possible solutions. Included are studies of acute direct effects of drugs, effects of drugs on task-related activation, chronic effects of drugs, effects of drugs on cerebral metabolism, and variable effects of drugs in different populations. Psychopharmacology Bulletin. 2002;36(1):102-129
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Paulus, M. P., Feinstein, J. S., Castillo, G., Simmons, A. N., & Stein, M. B. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.282 · Cited by 314
“Pharmacological fMRI is an emerging discipline with the potential to address a variety of neural systems and drug development questions.(21) One important consideration with pharmacological fMRI is the differentiation between the drug’s effect on neural tissue or on hemodynamic modulation.”
BackgroundModel‐free arterial spin labeling quantification approach for perfusion MRI
Petersen, E. T., Lim, T., & Golay, X. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20784 · Cited by 305
Perfusion Imaging Using Arterial Spin Labeling
Golay, X., Hendrikse, J., & Lim, T. C. C. (2004) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200402000-00003 · Cited by 256
Thiel, C. M., Zilles, K., & Fink, G. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300633 · Cited by 182
Amphetamine modulates human incentive processing
Knutson, B., Bjork, J. M., Fong, G. W., Hommer, D., Mattay, V. S., & Weinberger, D. R. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.030 · Cited by 174
“…informed consent,behavioral performance, which often changes as a funcand the protocol was approved by the Institutional Review Board tion of AMPH treatment (Salmeron and Stein, 2002), but of the National Institutes of Mental Health. which was controlled for in this paradigm (i.e., hit rate).”
Method
Metadata
- Authors
- Salmeron, B. J., MD, Stein, A. E. A., & PhD
- Venue
- Psychopharmacology Bulletin
- Publisher
- Medworks Media Inc.
- Published
- 2025-08-12
- Volume
- 36
- Issue
- 1
- Pages
- 102-129
- ISSN
- 0048-5764 (ISSN-L)
- 2472-2448
- OpenAlex
- W2409893367
- Cited by
- 61
- References
- 0
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological Applications of Magnetic Resonance Imaging. https://app.cochat.ai/papers/10.64719/pb.4234
- The paper
- Salmeron, B. J., MD, Stein, A. E. A., & PhD. (2025). Pharmacological Applications of Magnetic Resonance Imaging. Psychopharmacology Bulletin. https://doi.org/10.64719/pb.4234
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.